Terms: = Liver cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Diagnosis
70 results:
1. Diagnostic performance of PIVKA-II in identifying recurrent hepatocellular carcinoma following curative resection: a retrospective cohort study.
Zhu W; Wang W; Zheng W; Chen X; Wang X; Xie J; Jiang S; Chen H; Zhu S; Xue P; Jiang X; Li H; Wang G
Sci Rep; 2024 Apr; 14(1):8416. PubMed ID: 38600210
[TBL] [Abstract] [Full Text] [Related]
2. BRCC36 Deubiquitinates HMGCR to Regulate the Interplay Between Ferroptosis and Pyroptosis.
Wang H; Shu L; Lv C; Liu N; Long Y; Peng X; Ling H; Tao T; Tang J; Cheng Y; Liu S; Xiao D; Tao Y
Adv Sci (Weinh); 2024 Mar; 11(11):e2304263. PubMed ID: 38178583
[TBL] [Abstract] [Full Text] [Related]
3. FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinoma.
Tang X; Luo B; Huang S; Jiang J; Chen Y; Ren W; Shi X; Zhang W; Shi L; Zhong X; Lü M
Eur J Med Res; 2023 Oct; 28(1):419. PubMed ID: 37821996
[TBL] [Abstract] [Full Text] [Related]
4. Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma.
Cowzer D; White JB; Chou JF; Chen PJ; Kim TH; Khalil DN; El Dika IH; Columna K; Yaqubie A; Light JS; Shia J; Yarmohammadi H; Erinjeri JP; Wei AC; Jarnagin W; Do RKG; Solit DB; Capanu M; Shah RH; Berger MF; Abou-Alfa GK; Harding JJ
JCO Precis Oncol; 2023 Sep; 7():e2300272. PubMed ID: 37769223
[TBL] [Abstract] [Full Text] [Related]
5. [A Case of Rectal Neuroendocrine Carcinoma with iris Metastasis].
Matsuo Y; Ichikawa Y; Sawada G; Takada A; Kim HM; Murakami M; Fukunaga H; Shirai S; Kondou S; Kimura H; Morita S
Gan To Kagaku Ryoho; 2023 May; 50(5):647-649. PubMed ID: 37218331
[TBL] [Abstract] [Full Text] [Related]
6. A novel predictive model of microvascular invasion in hepatocellular carcinoma based on differential protein expression.
Wang Z; Cao L; Wang J; Wang H; Ma T; Yin Z; Cai W; Liu L; Liu T; Ma H; Zhang Y; Shen Z; Zheng H
BMC Gastroenterol; 2023 Mar; 23(1):89. PubMed ID: 36973651
[TBL] [Abstract] [Full Text] [Related]
7. iris metastasis as resistance mechanism to atezolizumab, carboplatin, and etoposide but responds to additional irinotecan and anlotinib in a small cell lung cancer patient.
Huang Z; Zhang Y
Thorac Cancer; 2023 Mar; 14(8):779-782. PubMed ID: 36747371
[TBL] [Abstract] [Full Text] [Related]
8. Pathologic complete response following FOLFIRINOX and olaparib treatment for hepatic metastasized pancreatic ductal adenocarcinoma with a germline BRCA mutation.
Okada K; Uemura K; Okamoto W; Sumiyoshi T; Shintakuya R; Otsuka H; Serikawa M; Ishii Y; Arihiro K; Takahashi S
Clin J Gastroenterol; 2023 Apr; 16(2):283-288. PubMed ID: 36574187
[TBL] [Abstract] [Full Text] [Related]
9. The Value of Nuclear Magnetic Resonance in liver Nodular Lesions.
Chen S; Bao J
Contrast Media Mol Imaging; 2022; 2022():8165950. PubMed ID: 36017027
[TBL] [Abstract] [Full Text] [Related]
10. Differentiation of hepatic alveolar echinococcosis with a hemangioma-like pattern compared to typical liver hemangioma using contrast-enhanced ultrasound: a pilot study.
Philipp J; Schmidberger J; Schlingeloff P; Kratzer W
Infection; 2023 Feb; 51(1):159-168. PubMed ID: 35776381
[TBL] [Abstract] [Full Text] [Related]
11. Leptomeningeal disease in BRIP1-mutated pancreatic adenocarcinoma.
Yim E; Leung D
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35675963
[TBL] [Abstract] [Full Text] [Related]
12. Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer.
Minoura Y; Takahashi M; Maeda H; Kuwahara S; Tachikawa H; Yamamoto M; Tomioka N; Watanabe K; Sakurai A
Breast Cancer; 2022 Sep; 29(5):808-813. PubMed ID: 35641852
[TBL] [Abstract] [Full Text] [Related]
13. Association of Pathogenic Variants in Hereditary cancer Genes With Multiple Diseases.
Zeng C; Bastarache LA; Tao R; Venner E; Hebbring S; Andujar JD; Bland ST; Crosslin DR; Pratap S; Cooley A; Pacheco JA; Christensen KD; Perez E; Zawatsky CLB; Witkowski L; Zouk H; Weng C; Leppig KA; Sleiman PMA; Hakonarson H; Williams MS; Luo Y; Jarvik GP; Green RC; Chung WK; Gharavi AG; Lennon NJ; Rehm HL; Gibbs RA; Peterson JF; Roden DM; Wiesner GL; Denny JC
JAMA Oncol; 2022 Jun; 8(6):835-844. PubMed ID: 35446370
[TBL] [Abstract] [Full Text] [Related]
14. Intraocular mass as first presenting symptom of metastatic squamous cell lung cancer.
Stenberg R; Mancini G; Guthrie T; Simon EL
Am J Emerg Med; 2021 Dec; 50():814.e1-814.e2. PubMed ID: 34275680
[TBL] [Abstract] [Full Text] [Related]
15. Integrated analysis of the functions and prognostic values of RNA binding proteins in hepatocellular carcinoma.
Wu ZH; Huang HM; Yang DL
BMC Gastroenterol; 2021 Jun; 21(1):265. PubMed ID: 34130650
[TBL] [Abstract] [Full Text] [Related]
16. Pathology of breast cancer metastasis and a view of metastasis to the brain.
Sakibuzzaman M; Mahmud S; Afroze T; Fathma S; Zakia UB; Afroz S; Zafar F; Hossain M; Barua A; Akter S; Chowdhury HI; Ahsan E; Eshan SH; Fariza TT
Int J Neurosci; 2023 May; 133(5):544-554. PubMed ID: 34044732
[TBL] [Abstract] [Full Text] [Related]
17. Patients presenting with metastases: stage IV uveal melanoma, an international study.
Garg G; Finger PT; Kivelä TT; Simpson ER; Gallie BL; Saakyan S; Amiryan AG; Valskiy V; Chin KJ; Semenova E; Seregard S; Filì M; Wilson M; Haik B; Caminal JM; Catala-Mora J; Gutiérrez C; Pelayes DE; Folgar AM; Jager MJ; Doğrusöz M; Luyten GPM; Singh AD; Suzuki S;
Br J Ophthalmol; 2022 Apr; 106(4):510-517. PubMed ID: 33452185
[TBL] [Abstract] [Full Text] [Related]
18. Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study.
Wang K; Wu Z; Wang G; Shi H; Xie J; Yin L; Xu T; Mao W; Peng B
Int Braz J Urol; 2021; 47(2):333-349. PubMed ID: 33284535
[TBL] [Abstract] [Full Text] [Related]
19. Development and validation of a web-based calculator to predict individualized conditional risk of site-specific recurrence in nasopharyngeal carcinoma: Analysis of 10,058 endemic cases.
Wu CF; Lv JW; Lin L; Mao YP; Deng B; Zheng WH; Wen DW; Chen Y; Kou J; Chen FP; Yang XL; Zheng ZQ; Li ZX; Xu SS; Ma J; Sun Y
Cancer Commun (Lond); 2021 Jan; 41(1):37-50. PubMed ID: 33270990
[TBL] [Abstract] [Full Text] [Related]
20. Percutaneous isolated hepatic perfusion (chemosaturation) with melphalan following right hemihepatectomy in patients with cholangiocarcinoma and metastatic uveal melanoma: peri- and post-interventional adverse events and therapy response compared to a matched group without prior liver surgery.
Dewald CLA; Becker LS; Maschke SK; Meine TC; Alten TA; Kirstein MM; Vogel A; Wacker FK; Meyer BC; Hinrichs JB
Clin Exp Metastasis; 2020 Dec; 37(6):683-692. PubMed ID: 33034815
[TBL] [Abstract] [Full Text] [Related]
[Next]
